Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-11-19 04:50 | 2019-11-14 | DS | N/A | ACACIA RESEARCH CORP | Director | Other | BUY | $4.15 | 500,000 | $2,076,300 | 500,000 | +100.0% |
| 2019-11-19 03:00 | 2019-11-14 | AGRX | N/A | PERCEPTIVE ADVISORS LLC | 10% owner | Other | BUY | $1.68 | 5,768,815 | $9,676,033 | 11,919,925 | +93.8% |
| 2019-11-18 15:57 | 2019-11-18 | KDMN | N/A | PERCEPTIVE ADVISORS LLC | Other | Other | BUY | $3.40 | 1,470,588 | $4,999,999 | 14,636,334 | +11.2% |
| 2019-11-19 00:48 | 2019-11-14 | RLH | N/A | Coliseum Capital Management, LLC | 10% owner | Other | BUY | $2.63 | 537,000 | $1,412,310 | 4,200,871 | +14.7% |
| 2019-11-16 00:40 | 2019-11-13 | SRACU | Momentus Inc. | Freedman Edward K. | 10% owner | Guided Missiles & Space Vehicles & Parts | BUY | $10.00 | 495,000 | $4,950,000 | 495,000 | +100.0% |
| 2019-11-16 00:39 | 2019-11-13 | SRACU | Momentus Inc. | Quiroga Juan Manuel | Officer, 10% owner - Chief Investment Officer | Guided Missiles & Space Vehicles & Parts | BUY | $10.00 | 495,000 | $4,950,000 | 495,000 | +100.0% |
| 2019-11-16 00:38 | 2019-11-13 | SRACU | Momentus Inc. | Kabot Brian | Director, Officer, 10% owner - Chief Executive Officer | Guided Missiles & Space Vehicles & Parts | BUY | $10.00 | 495,000 | $4,950,000 | 495,000 | +100.0% |
| 2019-11-16 00:35 | 2019-11-13 | SRACU | Momentus Inc. | SRC-NI Holdings LLC | 10% owner | Guided Missiles & Space Vehicles & Parts | BUY | $10.00 | 495,000 | $4,950,000 | 495,000 | +100.0% |
| 2019-11-16 00:59 | 2019-11-15 | NYNY | N/A | Kien Huat Realty III Ltd | 10% owner | Other | BUY | $9.74 | 5,523,691 | $53,800,750 | 34,438,297 | +19.1% |
| 2019-11-16 00:05 | 2019-11-13 | AGIO | Agios Pharmaceuticals Inc. | FOUSE JACQUALYN A | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $31.00 | 40,322 | $1,249,982 | 41,722 | +2,880.1% |
| 2019-11-16 01:57 | 2019-11-13 | OCX | Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $1.70 | 1,176,471 | $2,000,001 | 12,274,738 | +10.6% |
| 2019-11-15 22:52 | 2019-11-04 | RAPT | RAPT Therapeutics, Inc. | Topspin Fund L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.00 | 415,000 | $4,980,000 | 2,575,371 | +19.2% |
| 2019-11-16 00:22 | 2019-11-14 | UGI | UGI CORP /PA/ | HERMANCE FRANK S | Director | Gas & Other Services Combined | BUY | $42.70 | 150,000 | $6,404,430 | 400,000 | +60.0% |
| 2019-11-15 01:00 | 2019-11-12 | LGF-B | STARZ ENTERTAINMENT CORP /CN/ | Crawford Gordon | Director | Services-Motion Picture & Video Tape Production | BUY | $8.87 | 122,414 | $1,085,359 | 336,429 | +57.2% |
| 2019-11-15 01:00 | 2019-11-12 | GRTX | Galera Therapeutics, Inc. | Clarus IV-A, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.00 | 250,000 | $3,000,000 | 130,444 | +100.0% |
| 2019-11-15 00:23 | 2019-11-12 | ARVN | Arvinas Inc. | Ratcliffe Liam | Director | Pharmaceutical Preparations | BUY | $22.00 | 680,000 | $14,960,000 | 680,000 | +100.0% |
| 2019-11-15 01:51 | 2019-11-12 | HSAC | Immunovant, Inc. | WONG RODERICK | Director, Officer - Chief Executive Officer | Biological Products, (No Diagnostic Substances) | BUY | $10.17 | 126,000 | $1,281,420 | 156,500 | +413.1% |
| 2019-11-15 00:06 | 2019-11-12 | AGIO | Agios Pharmaceuticals Inc. | CELGENE CORP /DE/ | 10% owner | Pharmaceutical Preparations | BUY | $31.00 | 403,225 | $12,499,975 | 1,777,824 | +29.3% |
| 2019-11-15 00:35 | 2019-11-12 | TNET | TRINET GROUP, INC. | AGI-T, L.P. | Director, 10% owner | Services-Business Services, NEC | BUY | $54.41 | 61,000 | $3,318,943 | 2,912,187 | +2.1% |
| 2019-11-14 22:16 | 2019-11-12 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% owner, Other | Pharmaceutical Preparations | BUY | $12.00 | 500,000 | $6,000,000 | 3,409,021 | +17.2% |
| 2019-11-15 01:04 | 2019-11-12 | AGO | ASSURED GUARANTY LTD | Feldstein Andrew T | Officer - Chief Investment Officer | Surety Insurance | BUY | $48.31 | 25,222 | $1,218,349 | 354,788 | +7.7% |
| 2019-11-14 14:06 | 2019-11-13 | GDEN | GOLDEN ENTERTAINMENT, INC. | Marnell Anthony A. III | Director | Services-Miscellaneous Amusement & Recreation | BUY | $16.85 | 64,095 | $1,080,001 | 102,774 | +165.7% |
| 2019-11-15 01:00 | 2019-11-12 | GRTX | Galera Therapeutics, Inc. | Blackstone Clarus GP L.P. | 10% owner | Pharmaceutical Preparations | BUY | $12.00 | 250,000 | $3,000,000 | 130,444 | +100.0% |
| 2019-11-15 05:58 | 2019-11-13 | SMPL | Simply Good Foods Co | KILTS JAMES M | Director | Food and Kindred Products | BUY | $24.62 | 70,000 | $1,723,400 | 737,217 | +10.5% |
| 2019-11-14 03:07 | 2019-11-11 | ETNB | N/A | Naschitz Anat | Director, 10% owner | Other | BUY | $16.00 | 837,500 | $13,400,000 | 724,363 | +100.0% |
| 2019-11-14 03:04 | 2019-11-11 | ETNB | N/A | Grunberg Gregory | Director, 10% owner | Other | BUY | $16.00 | 575,000 | $9,200,000 | 575,000 | +100.0% |
| 2019-11-14 03:10 | 2019-11-11 | ETNB | N/A | Kariv Tomer | Director, 10% owner | Other | BUY | $16.00 | 250,000 | $4,000,000 | 250,000 | +100.0% |
| 2019-11-14 04:57 | 2019-11-08 | TELA | TELA Bio, Inc. | Zuga Matt | Director | Surgical & Medical Instruments & Apparatus | BUY | $13.00 | 86,121 | $1,119,573 | 260,808 | +49.3% |
| 2019-11-14 04:52 | 2019-11-08 | TELA | TELA Bio, Inc. | Azarbarzin Kurt | Director | Surgical & Medical Instruments & Apparatus | BUY | $13.00 | 86,121 | $1,119,573 | 260,808 | +49.3% |
| 2019-11-14 05:03 | 2019-11-08 | TELA | TELA Bio, Inc. | Quaker BioVentures II LP | 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $13.00 | 153,846 | $1,999,998 | 888,664 | +20.9% |
| 2019-11-14 00:33 | 2019-11-12 | CLNC | BrightSpire Capital, Inc. | Tangen Darren J. | Director | Real Estate Investment Trusts | BUY | $11.72 | 90,000 | $1,054,800 | 155,759 | +136.9% |
| 2019-11-14 00:34 | 2019-11-12 | CLNC | BrightSpire Capital, Inc. | Traenkle Kevin P. | Director, Officer - CEO AND PRESIDENT | Real Estate Investment Trusts | BUY | $11.93 | 100,000 | $1,193,000 | 274,877 | +57.2% |
| 2019-11-13 21:44 | 2019-11-11 | DBX | DROPBOX, INC. | Houston Andrew | Director, Officer, 10% owner - Chief Executive Officer | Services-Prepackaged Software | BUY | $19.14 | 500,000 | $9,568,900 | 500,000 | +100.0% |
| 2019-11-14 02:28 | 2019-11-11 | DEI | Douglas Emmett Inc | ANDERSON CHRISTOPHER H | Director | Real Estate Investment Trusts | BUY | $43.23 | 35,000 | $1,513,159 | 2,301,660 | +1.5% |
| 2019-11-14 01:58 | 2019-11-11 | TRN | TRINITY INDUSTRIES INC | Boze Brandon B | Director, 10% owner, Other | Railroad Equipment | BUY | $21.47 | 677,500 | $14,547,754 | 24,889,198 | +2.8% |
| 2019-11-14 04:48 | 2019-11-08 | TELA | TELA Bio, Inc. | Oliva Adele C | Director, 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $13.00 | 153,846 | $1,999,998 | 888,664 | +20.9% |
| 2019-11-14 03:06 | 2019-11-11 | ETNB | N/A | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Other | BUY | $16.00 | 1,500,000 | $24,000,000 | 1,500,000 | +100.0% |
| 2019-11-14 03:02 | 2019-11-11 | CODI | Compass Diversified Holdings | SABO ELIAS | Other | Household Furniture | BUY | $22.32 | 54,601 | $1,218,875 | 109,601 | +99.3% |
| 2019-11-14 03:02 | 2019-11-11 | ETNB | N/A | Longitude Capital Partners III, LLC | 10% owner | Other | BUY | $16.00 | 575,000 | $9,200,000 | 575,000 | +100.0% |
| 2019-11-14 03:30 | 2019-10-23 | GTE | GRAN TIERRA ENERGY INC. | GMT CAPITAL CORP | 10% owner | Crude Petroleum & Natural Gas | BUY | $1.15 | 2,803,800 | $3,218,482 | 79,974,486 | +3.6% |
| 2019-11-14 04:47 | 2019-11-08 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% owner | Surgical & Medical Instruments & Apparatus | BUY | $13.00 | 384,615 | $4,999,995 | 1,568,627 | +32.5% |
| 2019-11-14 03:00 | 2019-11-11 | ETNB | N/A | ORBIMED ADVISORS LLC | Director, 10% owner | Other | BUY | $16.00 | 837,500 | $13,400,000 | 724,363 | +100.0% |
| 2019-11-14 01:47 | 2019-11-12 | CCI | CROWN CASTLE INC. | MARTIN J LANDIS | Director | Real Estate Investment Trusts | BUY | $130.61 | 10,900 | $1,423,657 | 4,500 | +100.0% |
| 2019-11-12 18:07 | 2019-11-08 | N-A | N/A | STRS OHIO | 10% owner | Other | BUY | $15.00 | 333,333 | $5,000,000 | 5,939,597 | +5.9% |
| 2019-11-12 14:00 | 2019-11-08 | BKI | N/A | Jabbour Anthony M | Director, Officer - Chief Executive Officer | Other | BUY | $56.65 | 17,675 | $1,001,289 | 432,009 | +4.3% |
| 2019-11-12 20:19 | 2019-11-07 | PPR | Saba Capital Income & Opportunities Fund | Saba Capital Management, L.P. | 10% owner | Other | BUY | $4.84 | 872,922 | $4,225,728 | 21,979,225 | +4.1% |
| 2019-11-13 01:01 | 2019-11-07 | TNET | TRINET GROUP, INC. | AGI-T, L.P. | Director, 10% owner | Services-Business Services, NEC | BUY | $53.83 | 230,420 | $12,402,587 | 2,851,187 | +8.8% |
| 2019-11-12 18:56 | 2019-11-08 | N/A | N/A | Golub Lawrence E | Director, Officer - Chairman | Other | BUY | $15.00 | 125,035 | $1,875,525 | 405,379 | +44.6% |
| 2019-11-12 18:53 | 2019-11-08 | N/A | N/A | Golub David | Director, Officer - President and CEO | Other | BUY | $15.00 | 125,035 | $1,875,525 | 405,379 | +44.6% |
| 2019-11-13 01:02 | 2019-11-07 | AGO | ASSURED GUARANTY LTD | Feldstein Andrew T | Officer - Chief Investment Officer | Surety Insurance | BUY | $48.26 | 37,087 | $1,789,796 | 329,566 | +12.7% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.